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background: In the last years there has been a great interest in the role of the abnormalities of mineral metabolism and inflammation in 
cardiovascular disease. We have assessed the relationship between left ventricular hypertrophy (LVH), inflammation and mineral metabolism.
Methods: LVH was measured on echocardiography in 146 outpatients with stable coronary artery disease (SCAD). Patients with a diagnosis of 
cardiomyopathy were excluded. Plasma was stored at -80°C. Calcidiol (a metabolite of vitamin D), parathyroid hormone (PTH) and FGF-23 (fibroblast 
growth factor -23) plasma levels were determined in order to study the mineral metabolism. High sensitivity C-reactive protein, MCP-1 (monocyte 
chemoattractant protein-1), galectin-3, NGAL (neutrophil gelatinase-associated lipocalin), and TWEAK (TNF-related weak inducer of apoptosis) 
plasma levels were studied as markers of inflammation.
results: LVH, defined as septal thickness ≥ 11 mm, was present in 19.9% of cases. These patients were older [75.0 (61.0-81.0) vs 64.0 (51.0-
76.0) years; p=0.002], and had higher PTH [84.7 (59.6-104.7) vs 63.2 (49.2-85.2) pg/ml; p=0.007], galectin-3 [9.6 (8.0-11.1) vs 8.3 (6.9-9.9) 
ng/ml; p=0.037], and NGAL (208.5±87.6 vs 173.9±73.4 ng/ml; p=0.031) plasma levels than those without LVH. Oppositely, glomerular filtration 
rate was lower in patients with LVH than in those without it (65.1±20.0 vs 74.7±19.9 mL/min/1.73 m2; p=0.021). There were no significant 
differences in sex (62.1vs 65.0% men; p=0.83) and hypertension (79.3 vs 68.4%; p=0.363) between patients with and without LVH. Age, sex, 
hypertension, glomerular filtration rate, NGAL, logarithm PTH, and logarithm galectin-3 plasma levels were entered into a logistic regression analysis. 
Of these variables, only age [Odds Ratio 1.044 (1.004-1.085); p=0.031] and logarithm PTH [Odds Ratio14.787 (1.136-192.510), p=0.040] were 
independent predictors of the presence of LVH.
conclusions: In a population of patients with SCAD, elevated PTH levels are independently associated with the presence of LVH. Further studies 
are needed to elucidate the role of disorders of mineral metabolism in the development of myocardial hypertrophy.
